Parnassus Investments
CELG

Parnassus Investments’s Celgene Corp CELG Stock Holding History

Parnassus Investments’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-900,000
Closed -$84.9M – 101
2019
Q1 		$84.9M Sell
900,000
-1,900,000
-68% -$166M 0.33% 59
2018
Q4 		$179M Buy
2,800,000
+2,650,000
+1,767% +$196M 0.78% 45
2018
Q3 		$13.4M Buy
+150,000
New +$13.3M 0.05% 82

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Parnassus Investments's CELG Position: Q2 2019 in Review

Parnassus Investments sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 900,000 shares — an estimated $84.9M sold.

Parnassus Investments first reported a position in CELG in Q3 2018 and held it in 3 quarters. The position peaked at $179M in Q4 2018. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Parnassus Investments reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Parnassus Investments sold 900,000 Celgene Corp shares in Q2 2019, an estimated $84.9M.
  • Parnassus Investments first reported a position in Celgene Corp in Q3 2018 and held it in 3 quarters.
  • Parnassus Investments's Celgene Corp position peaked at $179M in Q4 2018.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Parnassus Investments's 13F filing for Q2 2019, filed 8 Aug 2019.